Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
PRRT2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Invitae Familial Hemiplegic Migraine Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 21 | 7 |
|
Invitae Cerebral Palsy Spectrum Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 638 | 419 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Genetic Services Laboratory University of Chicago United States | 289 | 481 |
|
PreventionGenetics, part of Exact Sciences United States | 17 | 17 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 466 | 297 |
|
Familial Hemiplegic Migraine and Alternating Hemiplegia of Childhood Panel PreventionGenetics, part of Exact Sciences United States | 13 | 8 |
|
Invitae Dystonia Comprehensive Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 61 | 38 |
|
Hemiplegic Migraine and PRRT2-Related Disorders via the PRRT2 Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 414 | 800 |
|
MNG Laboratories (Medical Neurogenetics, LLC.) United States | 54 | 45 |
|
Generalized idiopathic and focal epilepsy panel. 34-gene NGS panel. Genologica Medica Spain | 74 | 34 |
|
Hereditary ataxias. NGS panel of 139 genes. Genologica Medica Spain | 220 | 139 |
|
Ataxia panel. NGS panel of 157 genes. Genologica Medica Spain | 247 | 156 |
|
Migraine panel. NGS panel of 10 genes. Genologica Medica Spain | 30 | 10 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Dystonia panel. NGS panel of 20 genes. Genologica Medica Spain | 35 | 20 |
|
Ciliary dyskinesia and heterotaxia. NGS panel of 40 genes. Genologica Medica Spain | 49 | 40 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.